This review suggested that carotid endarterectomy was safer than carotid angioplasty, with or without stent placement, for patients with carotid stenosis suitable for surgery. However, the poor reporting of this review make it difficult to assess its' reliability, so a cautious interpretation of the findings is advised.
Included trials assessed participants with between 50% and over 80% stenosis. Just less than half of the trials recruited symptomatic and asymptomatic patients. The majority of included trials compared carotid angioplasty with stent placement (using the Wallstent) with the surgeons' preferred method for carotid endarterectomy. Successful deployment of the stent ranged from 89% to 100%. All included trials used an additional stent after primary angioplasty. Aspirin was usually given before carotid angioplasty with stent placement; in a number of cases, aspirin was given along with antiplatelet drug (ticlopidine or clopidogrel). A distal protection device was used in just less than half of the carotid angioplasty with stent placement interventions. Antiplatelet prophylaxis was also given in some cases before carotid endarterectomy. Follow-up usually occurred at 24 hours, one, six and/or 12 months. Outcome measures varied between trials, particularly with regard to the assessment of neurological status.
All three of the authors assessed the studies for inclusion.
Assessment of study quality
Study validity was independently assessed by two reviewers using the Jadad scale, each study been awarded a score up to a maximum of five points. Disagreements were resolved by a third reviewer. Overall quality was also assessed using a Dutch checklist.
Data extraction
Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for the main outcomes using intention-to-treat data.
The authors did not state how data were extracted for the review, or how many reviewers performed the data extraction.
Methods of synthesis
Studies were grouped according to outcome and pooled odds ratios with 95% confidence intervals were calculated using the Peto fixed-effect method. The Yates' correction was applied to any studies with zero events. Statistical heterogeneity was assessed using the χ2 and I 2 statistics. Further analyses were conducted using a random-effects analysis, and excluding various groups of trials based on study size, the use of distal protection devices and the inclusion of asymptomatic patients. Relative risks (RRs) were also calculated using a fixed effect analysis. Publication bias was assessed using funnel plots.
Results of the review
The authors reported including seven RCTs (n=1,480 carotid endarterectomy patients and n=1,492 carotid angioplasty with stent placement patients) in the review; the results of eight trials are included in the analyses. Blinding was not possible due the nature of the intervention and study design. Of the eight trials included in the analyses, all but one scored 3 points on the Jadad scale; the remaining trial scored 1 point. Sample sizes ranged from 17 to 1183; three trials recruited fewer than 105 patients.
A significant benefit for carotid endarterectomy over carotid angioplasty with stent placement was reported for death or any stroke at 30 days post-procedure (OR 1.39, 95% CI: 1.05 to 1.84; eight trials; I 2 =59.4%); the risk of death, any stoke, or myocardial infarction at 30 days (effect size not reported); ipsilateral ischaemic stroke at 30 days (OR 1.48, 95% CI: 1.05 to 2.07); any stroke at 30 days (OR 1.50, 95% CI: 1.05 to 2.16); death or stroke at six months follow-up (OR 1.99, 95% CI: 1.09 to 3.62); and the risk of procedural failure (OR 3.42, 95% CI: 2.03 to 5.79). I 2, χ 2 and number of included trials were not reported for many of the outcomes.
The risk of cranial neuropathy at 30 days (OR 1.99, 95% CI: 1.09 to 3.62; six trials) was significantly reduced for carotid angioplasty with stent placement in comparison with carotid endarterectomy.
No significant differences between the two procedures were reported for the odds of death or disabling stroke at 30 days (six trials), death or stroke at one year follow-up (four trials) and ipsilateral intracerebral bleeding at 30 days.
The results of further analyses were also reported in the review, but in the majority of cases did not significantly change the original findings.
Funnel plots showed no evidence of publication bias.
